Literature DB >> 24468414

Synthesis of 2',3',4'-trihydroxyflavone (2-D08), an inhibitor of protein sumoylation.

Yeong Sang Kim1, Samantha G L Keyser1, John S Schneekloth2.   

Abstract

Protein sumoylation is a dynamic posttranslational modification involved in diverse biological processes during cellular homeostasis and development. Recently sumoylation has been shown to play a critical role in cancer, although to date there are few small molecule probes available to inhibit enzymes involved in the SUMO conjugation process. As part of a program to identify and study inhibitors of sumoylation we recently reported the discovery that 2',3',4'-trihydroxyflavone (2-D08) is a cell permeable, mechanistically unique inhibitor of protein sumoylation. The work reported herein describes an efficient synthesis of 2-D08 as well as a structurally related but inactive isomer. We also report an unanticipated Wessely-Moser rearrangement that occurs under vigorous methyl ether deprotection conditions. This rearrangement likely gave rise to 2-D08 during a deprotection step, resulting in 2-D08 appearing as a contaminant in a screening well from a commercial supplier.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Flavone; Inhibitor; SUMO; Synthesis

Mesh:

Substances:

Year:  2014        PMID: 24468414      PMCID: PMC3970184          DOI: 10.1016/j.bmcl.2014.01.010

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  26 in total

1.  Reporting data from high-throughput screening of small-molecule libraries.

Authors:  James Inglese; Caroline E Shamu; R Kiplin Guy
Journal:  Nat Chem Biol       Date:  2007-08       Impact factor: 15.040

Review 2.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

3.  Kerriamycin B inhibits protein SUMOylation.

Authors:  Isao Fukuda; Akihiro Ito; Masakazu Uramoto; Hisato Saitoh; Hisashi Kawasaki; Hiroyuki Osada; Minoru Yoshida
Journal:  J Antibiot (Tokyo)       Date:  2009-03-06       Impact factor: 2.649

4.  Structure-radical scavenging activity relationships of flavonoids.

Authors:  Ameha Seyoum; Kaleab Asres; Fathy Kandeel El-Fiky
Journal:  Phytochemistry       Date:  2006-08-17       Impact factor: 4.072

5.  A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.

Authors:  Jessica D Kessler; Kristopher T Kahle; Tingting Sun; Kristen L Meerbrey; Michael R Schlabach; Earlene M Schmitt; Samuel O Skinner; Qikai Xu; Mamie Z Li; Zachary C Hartman; Mitchell Rao; Peng Yu; Rocio Dominguez-Vidana; Anthony C Liang; Nicole L Solimini; Ronald J Bernardi; Bing Yu; Tiffany Hsu; Ido Golding; Ji Luo; C Kent Osborne; Chad J Creighton; Susan G Hilsenbeck; Rachel Schiff; Chad A Shaw; Stephen J Elledge; Thomas F Westbrook
Journal:  Science       Date:  2011-12-08       Impact factor: 47.728

Review 6.  The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.

Authors:  Jaclyn R Gareau; Christopher D Lima
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12       Impact factor: 94.444

7.  Nuclear translocation of cellular retinoic acid-binding protein II is regulated by retinoic acid-controlled SUMOylation.

Authors:  Avijit Majumdar; Anca D Petrescu; Yin Xiong; Noa Noy
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

8.  Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate.

Authors:  Isao Fukuda; Akihiro Ito; Go Hirai; Shinichi Nishimura; Hisashi Kawasaki; Hisato Saitoh; Ken-Ichi Kimura; Mikiko Sodeoka; Minoru Yoshida
Journal:  Chem Biol       Date:  2009-02-27

9.  Elevated global SUMOylation in Ubc9 transgenic mice protects their brains against focal cerebral ischemic damage.

Authors:  Yang-Ja Lee; Yongshan Mou; Dragan Maric; Dace Klimanis; Sungyoung Auh; John M Hallenbeck
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

Review 10.  Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets.

Authors:  Lynn Bedford; James Lowe; Lawrence R Dick; R John Mayer; James E Brownell
Journal:  Nat Rev Drug Discov       Date:  2010-12-10       Impact factor: 84.694

View more
  24 in total

1.  UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8.

Authors:  Tomofusa Fukuyama; Toshio Kitamura; Tomoko Kozu
Journal:  Int J Hematol       Date:  2022-02-12       Impact factor: 2.490

Review 2.  Signalling mechanisms and cellular functions of SUMO.

Authors:  Alfred C O Vertegaal
Journal:  Nat Rev Mol Cell Biol       Date:  2022-06-24       Impact factor: 113.915

Review 3.  Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.

Authors:  Jixuan Gao; Hilda A Pickett
Journal:  Nat Rev Cancer       Date:  2022-07-05       Impact factor: 69.800

Review 4.  Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases.

Authors:  Jin-Taek Hwang; Ahyoung Lee; Changwon Kho
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

5.  Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.

Authors:  Peter Garcia; Abigail Harrod; Shruti Jha; Jessica Jenkins; Alex Barnhill; Holden Lee; Merritt Thompson; Jordan Pringle Williams; James Barefield; Ashton Mckinnon; Persia Suarez; Ananya Shah; Angela J Lowrey; Gretchen L Bentz
Journal:  Antiviral Res       Date:  2021-02-10       Impact factor: 5.970

6.  RAS GTPases are modified by SUMOylation.

Authors:  Byeong Hyeok Choi; Changyan Chen; Mark Philips; Wei Dai
Journal:  Oncotarget       Date:  2017-12-15

7.  Sumoylation of histone deacetylase 1 regulates MyoD signaling during myogenesis.

Authors:  Hosouk Joung; Sehee Kwon; Kyoung-Hoon Kim; Yun-Gyeong Lee; Sera Shin; Duk-Hwa Kwon; Yeong-Un Lee; Taewon Kook; Nakwon Choe; Jeong Chul Kim; Young-Kook Kim; Gwang Hyeon Eom; Hyun Kook
Journal:  Exp Mol Med       Date:  2018-01-12       Impact factor: 8.718

8.  K-Ras Lys-42 is crucial for its signaling, cell migration, and invasion.

Authors:  Byeong Hyeok Choi; Mark R Philips; Yuan Chen; Lou Lu; Wei Dai
Journal:  J Biol Chem       Date:  2018-09-18       Impact factor: 5.157

9.  Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury.

Authors:  Jing Huang; Ping Xie; Yuan Dong; Wei An
Journal:  Cell Death Differ       Date:  2020-10-27       Impact factor: 15.828

10.  2-D08 treatment regulates C2C12 myoblast proliferation and differentiation via the Erk1/2 and proteasome signaling pathways.

Authors:  Hyunju Liu; Su-Mi Lee; Hosouk Joung
Journal:  J Muscle Res Cell Motil       Date:  2021-06-17       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.